BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 24526060)

  • 1. 4.5-hour time window for intravenous thrombolysis with recombinant tissue-type plasminogen activator is established firmly.
    Schellinger PD; Köhrmann M
    Stroke; 2014 Mar; 45(3):912-3. PubMed ID: 24526060
    [No Abstract]   [Full Text] [Related]  

  • 2. The 4.5-hour time window for intravenous thrombolysis with intravenous tissue-type plasminogen activator is not firmly established.
    Wechsler LR
    Stroke; 2014 Mar; 45(3):914-5. PubMed ID: 24526061
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombolysis in the 3- to 4.5-hour window: what do ECASSkeptics want?
    Selim MH; Molina CA
    Stroke; 2014 Mar; 45(3):916-7. PubMed ID: 24526059
    [No Abstract]   [Full Text] [Related]  

  • 4. Intraarterial thrombolysis within the first three hours after acute ischemic stroke in selected patients.
    Moonis M
    Stroke; 2009 Jul; 40(7):2611-2. PubMed ID: 19443796
    [No Abstract]   [Full Text] [Related]  

  • 5. IV and IA thrombolytic stroke strategies are complementary.
    Donnan GA; Davis SM
    Stroke; 2009 Jul; 40(7):2615. PubMed ID: 19443794
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombolysis, community hospitals, and primary stroke center.
    Jeng JS
    Acta Neurol Taiwan; 2009 Mar; 18(1):1-2. PubMed ID: 19537567
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous recombinant tissue-type plasminogen activator in the extended time window and the US Food and Drug Administration: confused about the time.
    Wechsler LR; Jovin TG
    Stroke; 2012 Sep; 43(9):2517-9. PubMed ID: 22910892
    [No Abstract]   [Full Text] [Related]  

  • 8. Is intraarterial tPA within 3 hours the treatment of choice for selected stroke patients?: No.
    Lindley RI
    Stroke; 2009 Jul; 40(7):2613-4. PubMed ID: 19443793
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time.
    Minnerup J; Wersching H; Ringelstein EB; Schilling M; Schäbitz WR; Wellmann J; Berger K
    Stroke; 2011 Oct; 42(10):2838-43. PubMed ID: 21852612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current acute stroke trials and their potential impact on the therapeutic time window.
    Schellinger PD; Köhrmann M
    Expert Rev Neurother; 2012 Feb; 12(2):169-77. PubMed ID: 22288672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous or intra-arterial thrombolysis?: it's time to find the right approach for the right patient.
    Mattle HP
    Stroke; 2007 Jul; 38(7):2038-40. PubMed ID: 17540964
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thrombolytic therapy: formation and current practice of intravenous thrombolysis in acute ischemic stroke].
    Iavorskaia VA; Flomin IuV; D'olog NV; Grebeniuk AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; Suppl 15():13-27. PubMed ID: 16447549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised trials of endovascular treatment of stroke are needed.
    Ciccone A; Sterzi R
    Lancet Neurol; 2010 Jan; 9(1):30; author reply 31-2. PubMed ID: 20083033
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thrombolysis in stroke--results of the ECASS study (European Cooperative Acute Stroke Study)].
    Nervenarzt; 1995 Aug; 66(8 Suppl):1-8. PubMed ID: 9131091
    [No Abstract]   [Full Text] [Related]  

  • 15. Estimated weight is not a reliable measure for dosing tissue plasminogen activator for thrombolysis in acute ischaemic stroke.
    Gill D; Halsey L; Kalkat H; Patel S; Kar A
    Int J Stroke; 2016 Feb; 11(2):NP25-6. PubMed ID: 26783320
    [No Abstract]   [Full Text] [Related]  

  • 16. Yes, intravenous thrombolysis should be administered in pregnancy when other clinical and imaging factors are favorable.
    Demchuk AM
    Stroke; 2013 Mar; 44(3):864-5. PubMed ID: 23391770
    [No Abstract]   [Full Text] [Related]  

  • 17. Systemic thrombolysis with rt-PA in patients under 40 years of age: a subgroup analysis of the Cologne Stroke Experience.
    Galldiks N; Zaro-Weber O; Dohmen C; Neveling M; Haupt WF; Fink GR; Sobesky J
    Cerebrovasc Dis; 2010; 30(5):514-8. PubMed ID: 20861623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised trials of endovascular treatment of stroke are needed.
    Schott AM
    Lancet Neurol; 2010 Jan; 9(1):30-1. PubMed ID: 20083032
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcomes of Thai patients with acute ischemic stroke after intravenous thrombolysis.
    Dharmasaroja PA; Dharmasaroja P; Muengtaweepongsa S
    J Neurol Sci; 2011 Jan; 300(1-2):74-7. PubMed ID: 20937509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment on "Intravenous thrombolysis for acute ischemic stroke: the Malabar experience 2003 to 2008".
    Sharma VK; Teoh HL; Chan BP
    J Clin Neurosci; 2010 Apr; 17(4):543-4. PubMed ID: 20167497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.